Robert Khalil
Child & Adolescent Psychiatry · Danbury, CTNPI 1205083359
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 155 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $23.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$618
- Lundbeck LLC$530
- Supernus Pharmaceuticals, Inc.$347
- Ironshore Pharmaceuticals Inc.$289
- Axsome Therapeutics, Inc.$263
- Corium, LLC$233
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,648100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,648 in reported general payments places this provider in the 90th percentile of 71 child & adolescent psychiatry providers in Connecticut.
See all child & adolescent psychiatry providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 16 | $1,409 |
| Clonazepam | 51 | $886 |
| Risperidone OdtRisperidone | 25 | $559 |
| Bumetanide | 17 | $456 |
| Carbamazepine ErCarbamazepine | 17 | $413 |
| Doxepin Hcl | 13 | $185 |
| Lorazepam | 18 | $105 |
| Risperidone | 14 | $67 |
| Quetiapine Fumarate | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Danbury
- Daniel KelleherDanbury$10K
- Aura ArdonDanbury$3K
- Tamar HanflingDanbury$3K
- Kathleen RiveraDanbury$319
- Steven SpectorPlantsville$278K
- Claudia CarbonariGlastonbury$12K
- Cornelia GalloWestport$7K
- Allan JacobsWest Hartford$5K
- Ammar TraboulsiNew London$3K
- Mirjana DomakondaHartford$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.